Shanghai Pharmaceuticals Holding Co. Ltd. Class ASSE: 601607

"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Approval for Production of Ruxolitinib Phosphate Tablets

Sep 1, 2026 · Issued by Shanghai Pharmaceuticals Holding Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Approval for Production of Ruxolitinib Phosphate Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shanghai Pharmaceuticals Holding Co. Ltd. Class A

"Shanghai Pharmaceuticals Holding Co., Ltd."Semi-annual Report for 2026Aug 28
"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Resolutions of the 3rd Meeting of the 9th Board of DirectorsAug 25
"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Approval for Production of Omeprazole and Sodium Bicarbonate Dry Suspension (I)Aug 4
"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Obtaining Canadian Product Licenses for DRAGON & TIGER Qingliang You Regular (Cooling Ointment), DRAGON & TIGER Qingliang You Ultra (Cooling Ointment) and DRAGON & TIGER Fengyou Jing Oil (Roll-On Medicated Oil)Jul 31

All Shanghai Pharmaceuticals Holding Co. Ltd. Class A news releases